Home > PE Ratio > SHILPA MEDICARE

SHILPA MEDICARE
PE (Price/Earnings) Ratio

The Current P/E Ratio of SHILPA MEDICARE is 109.11.

Share Price ₹740.0Feb 05,2025
Market Cap ₹7,236.7 Cr
Earnings-TTM₹66.3 CrTTM-Consolidated Results
Price/Earnings109.11xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SHILPA MEDICARE
Please provide your vote to see the results
SHILPA MEDICARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SHILPA MEDICARE

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SHILPA MEDICARE is calculated as :

Current Market Cap [ ₹7,236.7 Cr] as on Feb 05,2025

(/) Earnings [ ₹66.3 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 109.11x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SHILPA MEDICARE , the investors are currently willing to pay 109.11 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHILPA MEDICARE !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SHILPA MEDICARE over the last five years.

Historical PE (Price/Earnings) ratio chart of SHILPA MEDICARE


PE Ratio Performance Analysis for SHILPA MEDICARE

- SHILPA MEDICARE 's latest p/e ratio is 109.11x.

- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 42.73x.

- SHILPA MEDICARE 's operated at median p/e ratio of 18.41x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2024 at 125.64x.

- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does SHILPA MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SHILPA MEDICARE 66.32109.117,236.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0036.63420,699.0
CIPLA LTD5,000.4323.20116,022.0
DR REDDYS LABORATORIES LTD5,428.6018.87102,463.0
ZYDUS LIFESCIENCES LTD4,591.8021.4498,434.8
DIVIS LABORATORIES LTD2,067.0078.66162,584.0
MANKIND PHARMA LTD2,050.7349.96102,447.0
TORRENT PHARMACEUTICALS LTD1,862.0056.63105,449.0
LUPIN LTD2,651.9437.6499,816.4
AUROBINDO PHARMA LTD3,598.8319.2369,222.8
ABBOTT INDIA LTD1,334.4644.2459,040.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHILPA MEDICARE 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.87x
Max industry PE 109.11x
Median industry PE 37.64x
Average industry PE 45.06x



You may also like the below Video Courses